Bicara Therapeutics Expands Clinical Team with Appointments of Jeltje Schulten, M.D., MBA, as SVP of Clinical and Medical Affairs
Bicara Therapeutics Expands Clinical Team with Appointments of Jeltje Schulten, M.D., MBA, as SVP of Clinical and Medical Affairs
Bicara Therapeutics, a clinical-stage biotechnology company developing dual-action biologics to elicit a potent and durable immune response, today announced the appointments of Jeltje Schulten, M.D., MBA, as SVP of clinical and medical affairs
Read the article: https://www.bioqubeventures.com/bicara-therapeutics-expands-clinical-team-with-appointments-of-jeltje-schulten-m-d-mba-as-svp-of-clinical-and-medical-affairs-and-rita-dalal-mbbs-mph-as-vp-of-clinical-development/
Participants
Jeltje Schulten
Role: Alumni
Reference type: Featured
Media Outlets
Bioqube Ventures (Magazine)
RSM uses cookies to measure website statistics, enable social media sharing and for marketing purposes.
By clicking accept cookies or by continuing to use this website, you are giving consent for us to set cookies when visiting this website.
See our cookie policy for more information about cookies and how to adjust your cookie settings.